InvestorsHub Logo
Followers 8
Posts 1295
Boards Moderated 0
Alias Born 04/13/2016

Re: fred198484 post# 16819

Tuesday, 08/22/2017 4:24:46 PM

Tuesday, August 22, 2017 4:24:46 PM

Post# of 232330
You again are really working hard to find fault with pro 140. even if your argument turns out to be true you are looking at just the MDR market. it is splitting hairs and there is plenty more market for pro 140 than ibalizumab. Tai-med is not pursuing ibalizumab as a mono treatment at all. Also, I don't think most of us are really thinking about the value of pro 140 when it is on the market - we are thinking more about the value of cydy stock when it gets bought out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News